CBD (Cannabidiol) Product Attitudes, Knowledge, and Use Among Young Adults

被引:80
作者
Wheeler, Meghann [1 ]
Merten, Julie Williams [1 ]
Gordon, Benjamin T. [2 ]
Hamadi, Hanadi [3 ]
机构
[1] Univ North Florida, Dept Publ Hlth, Jacksonville, FL 32224 USA
[2] Univ Florida, Coll Hlth & Human Performance, Gainesville, FL USA
[3] Univ North Florida, Dept Hlth Adm, Jacksonville, FL USA
关键词
Cannabidiol; young adults; dietary supplements; patient education; CBD; DIETARY-SUPPLEMENTS; CYTOCHROME-P450; MARIJUANA;
D O I
10.1080/10826084.2020.1729201
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Cannabidiol (CBD), a non-psychoactive component of cannabis is marketed as a potential treatment for many conditions and widely available to purchase as a dietary supplement. In 2017, sales of CBD exceeded 820 million dollars despite many unconfirmed health claims, murky legality, and limited product efficacy and safety testing. Purpose/Objectives: This study aims to explore cannabidiol (CBD) knowledge, attitudes, and use among young adults. Methods: The anonymous 36-item survey developed using Qualtrics was distributed via social media from November 2018 to January 2019 with 340 respondents. Results: Of the 340 respondents, 242 reported they had heard of CBD, and 135 reported using CBD products. CBD users were primarily white, female, without children, made less than $25,000 per year, and unmarried. Most commonly used CBD products were edibles (56.30%), tinctures (54.07%), and vape (38.52%). Top reasons for use included stress relief (65.39%), relaxation (54.81%), and sleep improvement (42.22%). Many respondents reported using guesswork to determine dosage, and over half of respondents reported at least one unanticipated side effect. Conclusions/Importance: This study revealed that many users are not responsibly using CBD products, many believe CBD products provide health benefits that are not yet scientifically proven, and they are not knowledgeable about legal and regulatory issues. Until CBD use is more thoroughly researched and has more comprehensive regulation, public health professionals should address alternative stress and anxiety treatment methods.
引用
收藏
页码:1138 / 1145
页数:8
相关论文
共 45 条
[1]   Cannabis in painful HIV-associated sensory neuropathy - A randomized placebo-controlled trial [J].
Abrams, D. I. ;
Jay, C. A. ;
Shade, S. B. ;
Vizoso, H. ;
Reda, H. ;
Press, S. ;
Kelly, M. E. ;
Rowbotham, M. C. ;
Petersen, K. L. .
NEUROLOGY, 2007, 68 (07) :515-521
[2]   Evolution of the Cannabinoid and Terpene Content during the Growth of Cannabis sativa Plants from Different Chemotypes [J].
Aizpurua-Olaizola, Oier ;
Soydaner, Umut ;
Oeztuerk, Ekin ;
Schibano, Daniele ;
Simsir, Yilmaz ;
Navarro, Patricia ;
Etxebarria, Nestor ;
Usobiaga, Aresatz .
JOURNAL OF NATURAL PRODUCTS, 2016, 79 (02) :324-331
[3]  
[Anonymous], 2018, EPIDIOLEX HIGHLIGHTS
[4]  
Axon David Rhys, 2017, Am J Pharm Educ, V81, P6854, DOI 10.5688/ajpe6854
[5]   Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naive Social Phobia Patients [J].
Bergamaschi, Mateus M. ;
Costa Queiroz, Regina Helena ;
Nisihara Chagas, Marcos Hortes ;
Gomes de Oliveira, Danielle Chaves ;
De Martinis, Bruno Spinosa ;
Kapczinski, Flavio ;
Quevedo, Joao ;
Roesler, Rafael ;
Schroeder, Nadja ;
Nardi, Antonio E. ;
Martin-Santos, Rocio ;
Cecilio Hallak, Jaime Eduardo ;
Zuardi, Antonio Waldo ;
Crippa, Jose Alexandre S. .
NEUROPSYCHOPHARMACOLOGY, 2011, 36 (06) :1219-1226
[6]   Labeling Accuracy of Cannabidiol Extracts Sold Online [J].
Bonn-Miller, Marcel O. ;
Loflin, Mallory J. E. ;
Thomas, Brian F. ;
Marcu, Jahan P. ;
Hyke, Travis ;
Vandrey, Ryan .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (17) :1708-1709
[7]   INDUCTION AND GENETIC-REGULATION OF MOUSE HEPATIC CYTOCHROME-P450 BY CANNABIDIOL [J].
BORNHEIM, LM ;
EVERHART, ET ;
LI, JM ;
CORREIA, MA .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (01) :161-171
[8]  
BORNHEIM LM, 1990, MOL PHARMACOL, V38, P319
[9]   Cannabidiol, neuroprotection and neuropsychiatric disorders [J].
Campos, Alline C. ;
Fogaca, Manoela V. ;
Sonego, Andreza B. ;
Guimaraes, Francisco S. .
PHARMACOLOGICAL RESEARCH, 2016, 112 :119-127
[10]   Presence of Banned Drugs in Dietary Supplements Following FDA Recalls [J].
Cohen, Pieter A. ;
Maller, Gregory ;
DeSouza, Renan ;
Neal-Kababick, James .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (16) :1691-1693